Article: Selective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy

File Download Links for fulltext
(May Require Subscription)
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleSelective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy
AuthorsHo, CL2
Lai, JSM4
Aquino, MV5
Rojanapongpun, P3
Wong, HT7
Aquino, MC8
Gerber, Y6
Belkin, M
Barkana, Y1
KeywordsAngle closure
Angle closure glaucoma
Glaucoma
Iridotomy
Selective laser trabeculoplasty
Issue Date2009
PublisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.glaucomajournal.com
CitationJournal Of Glaucoma, 2009, v. 18 n. 7, p. 563-566 [How to Cite?]
DOI: http://dx.doi.org/10.1097/IJG.0b013e318193c2d1
AbstractPURPOSE: To determine whether selective laser trabeculoplasty (SLT) can lower intraocular pressure (IOP) in eyes with chronic primary angle closure, elevated IOP, and a patent iridotomy. PATIENTS AND METHODS: Patients with chronic angle closure who had underwent iridotomy, had an IOP greater than 21 mm Hg and a gonioscopically visible pigmented trabecular meshwork for at least 90 degrees were enrolled. SLT was applied to open angle segments. Duration of follow-up was 6 months. RESULTS: Sixty eyes of 60 patients were enrolled. The mean baseline IOP was 24.6±2.5 mm Hg. At 6 months, IOP reduction of ≥3 mm Hg or 4 mm Hg was measured in 82% and 72% of eyes, respectively, and IOP reduction of ≥20% or 30% was measured in 54% and 24% of eyes, respectively. When only eyes that were treated with the same number or fewer medications were considered, these IOP reductions were measured in 67%, 58%, 43%, and 15%, respectively. During the study period 1 eye (1.7%) required trabeculectomy owing to IOP elevation shortly after the SLT. There were no other significant complications attributable to SLT. CONCLUSIONS: SLT seems to be a safe and effective method of reducing IOP in many eyes with primary angle closure and a patent iridotomy in which there is a sufficient extent of visible trabecular meshwork. © 2009 Lippincott Williams & Wilkins, Inc.
ISSN1057-0829
2011 Impact Factor: 1.776
2011 SCImago Journal Rankings: 0.156
DOIhttp://dx.doi.org/10.1097/IJG.0b013e318193c2d1
ISI Accession Number IDWOS:000269939200011
ReferencesReferences in Scopus
DC Field
Value
dc.contributor.authorHo, CL
dc.contributor.authorLai, JSM
dc.contributor.authorAquino, MV
dc.contributor.authorRojanapongpun, P
dc.contributor.authorWong, HT
dc.contributor.authorAquino, MC
dc.contributor.authorGerber, Y
dc.contributor.authorBelkin, M
dc.contributor.authorBarkana, Y
dc.date.accessioned2010-09-06T10:09:05Z
dc.date.available2010-09-06T10:09:05Z
dc.date.issued2009
dc.description.abstractPURPOSE: To determine whether selective laser trabeculoplasty (SLT) can lower intraocular pressure (IOP) in eyes with chronic primary angle closure, elevated IOP, and a patent iridotomy. PATIENTS AND METHODS: Patients with chronic angle closure who had underwent iridotomy, had an IOP greater than 21 mm Hg and a gonioscopically visible pigmented trabecular meshwork for at least 90 degrees were enrolled. SLT was applied to open angle segments. Duration of follow-up was 6 months. RESULTS: Sixty eyes of 60 patients were enrolled. The mean baseline IOP was 24.6±2.5 mm Hg. At 6 months, IOP reduction of ≥3 mm Hg or 4 mm Hg was measured in 82% and 72% of eyes, respectively, and IOP reduction of ≥20% or 30% was measured in 54% and 24% of eyes, respectively. When only eyes that were treated with the same number or fewer medications were considered, these IOP reductions were measured in 67%, 58%, 43%, and 15%, respectively. During the study period 1 eye (1.7%) required trabeculectomy owing to IOP elevation shortly after the SLT. There were no other significant complications attributable to SLT. CONCLUSIONS: SLT seems to be a safe and effective method of reducing IOP in many eyes with primary angle closure and a patent iridotomy in which there is a sufficient extent of visible trabecular meshwork. © 2009 Lippincott Williams & Wilkins, Inc.
dc.description.natureLink_to_subscribed_fulltext
dc.identifier.citationJournal Of Glaucoma, 2009, v. 18 n. 7, p. 563-566 [How to Cite?]
DOI: http://dx.doi.org/10.1097/IJG.0b013e318193c2d1
dc.identifier.doihttp://dx.doi.org/10.1097/IJG.0b013e318193c2d1
dc.identifier.epage566
dc.identifier.hkuros165640
dc.identifier.isiWOS:000269939200011
dc.identifier.issn1057-0829
2011 Impact Factor: 1.776
2011 SCImago Journal Rankings: 0.156
dc.identifier.issue7
dc.identifier.openurl
dc.identifier.pmid19745672
dc.identifier.scopuseid_2-s2.0-70349755995
dc.identifier.spage563
dc.identifier.urihttp://hdl.handle.net/10722/90345
dc.identifier.volume18
dc.languageeng
dc.publisherLippincott Williams & Wilkins. The Journal's web site is located at http://www.glaucomajournal.com
dc.publisher.placeUnited States
dc.relation.ispartofJournal of Glaucoma
dc.relation.referencesReferences in Scopus
dc.rightsJournal of Glaucoma. Copyright © Lippincott Williams & Wilkins.
dc.subjectAngle closure
dc.subjectAngle closure glaucoma
dc.subjectGlaucoma
dc.subjectIridotomy
dc.subjectSelective laser trabeculoplasty
dc.titleSelective laser trabeculoplasty for primary angle closure with persistently elevated intraocular pressure after iridotomy
dc.typeArticle
Author Affiliations
  1. Assaf Harofeh Medical Center
  2. Singapore National Eye Centre
  3. Chulalongkorn University
  4. United Christian Hospital Hong Kong
  5. St. Luke's Medical Center Quezon City
  6. Tel Aviv University
  7. Tan Tock Seng Hospital
  8. National University Hospital, Singapore